272 related articles for article (PubMed ID: 28634816)
1. Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
Spear TT; Wang Y; Foley KC; Murray DC; Scurti GM; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
Cancer Immunol Immunother; 2017 Nov; 66(11):1411-1424. PubMed ID: 28634816
[TBL] [Abstract][Full Text] [Related]
2. Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
Spear TT; Wang Y; Smith TW; Simms PE; Garrett-Mayer E; Hellman LM; Baker BM; Nishimura MI
Mol Ther; 2018 Apr; 26(4):996-1007. PubMed ID: 29503203
[TBL] [Abstract][Full Text] [Related]
3. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
Front Immunol; 2017; 8():894. PubMed ID: 28804489
[TBL] [Abstract][Full Text] [Related]
4. TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependence.
Spear TT; Foley KC; Garrett-Mayer E; Nishimura MI
J Leukoc Biol; 2018 May; 103(5):973-983. PubMed ID: 29350789
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.
Balasiddaiah A; Davanian H; Aleman S; Pasetto A; Frelin L; Sällberg M; Lohmann V; Koh S; Bertoletti A; Chen M
J Virol; 2017 May; 91(9):. PubMed ID: 28228595
[TBL] [Abstract][Full Text] [Related]
6. Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.
Spear TT; Evavold BD; Baker BM; Nishimura MI
Cancer Immunol Immunother; 2019 Nov; 68(11):1881-1889. PubMed ID: 31595324
[TBL] [Abstract][Full Text] [Related]
7. TCR affinity and tolerance mechanisms converge to shape T cell diabetogenic potential.
Bettini M; Blanchfield L; Castellaw A; Zhang Q; Nakayama M; Smeltzer MP; Zhang H; Hogquist KA; Evavold BD; Vignali DA
J Immunol; 2014 Jul; 193(2):571-9. PubMed ID: 24943217
[TBL] [Abstract][Full Text] [Related]
8. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
[TBL] [Abstract][Full Text] [Related]
9. Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.
Lorenz FKM; Ellinger C; Kieback E; Wilde S; Lietz M; Schendel DJ; Uckert W
Hum Gene Ther; 2017 Dec; 28(12):1158-1168. PubMed ID: 28950731
[TBL] [Abstract][Full Text] [Related]
10. Modulation of T cell function by TCR/pMHC binding kinetics.
Carreño LJ; González PA; Kalergis AM
Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
[TBL] [Abstract][Full Text] [Related]
11. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ
Blood; 2011 Jul; 118(2):319-29. PubMed ID: 21606483
[TBL] [Abstract][Full Text] [Related]
12. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo.
Gottschalk RA; Corse E; Allison JP
J Exp Med; 2010 Aug; 207(8):1701-11. PubMed ID: 20660617
[TBL] [Abstract][Full Text] [Related]
13. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
14. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
[TBL] [Abstract][Full Text] [Related]
15. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
Duong MN; Erdes E; Hebeisen M; Rufer N
J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
[TBL] [Abstract][Full Text] [Related]
16. T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells.
Tan MP; Gerry AB; Brewer JE; Melchiori L; Bridgeman JS; Bennett AD; Pumphrey NJ; Jakobsen BK; Price DA; Ladell K; Sewell AK
Clin Exp Immunol; 2015 May; 180(2):255-70. PubMed ID: 25496365
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for self-recognition by autoimmune T-cell receptors.
Yin Y; Li Y; Mariuzza RA
Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
[TBL] [Abstract][Full Text] [Related]
18. Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
Zhang Y; Liu Y; Moxley KM; Golden-Mason L; Hughes MG; Liu T; Heemskerk MH; Rosen HR; Nishimura MI
PLoS Pathog; 2010 Jul; 6(7):e1001018. PubMed ID: 20686664
[TBL] [Abstract][Full Text] [Related]
19. Probing the Conformational Dynamics of Affinity-Enhanced T Cell Receptor Variants upon Binding the Peptide-Bound Major Histocompatibility Complex by Hydrogen/Deuterium Exchange Mass Spectrometry.
Merkle PS; Trabjerg E; Hongjian S; Ferber M; Cuendet MA; Jørgensen TJD; Luescher I; Irving M; Zoete V; Michielin O; Rand KD
Biochemistry; 2021 Mar; 60(11):859-872. PubMed ID: 33689297
[TBL] [Abstract][Full Text] [Related]
20. A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
Cho HI; Kim UH; Shin AR; Won JN; Lee HJ; Sohn HJ; Kim TG
Br J Cancer; 2018 Feb; 118(4):534-545. PubMed ID: 29360818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
